What is Mounjaro and How it works?

The fight against chronic diseases like type 2 diabetes and obesity has seen a significant breakthrough with the introduction of Mounjaro—a novel medication powered by the active ingredient tirzepatide. Originally developed by Eli Lilly and approved by the U.S. FDA in 2022, Mounjaro has recently been introduced in India, creating buzz across the healthcare industry. As both a glucose-lowering and weight-reducing medication, Mounjaro represents a powerful dual-action therapy that could change the way millions manage their health.

What is Mounjaro?

Mounjaro is a once-weekly injectable medication primarily prescribed for type 2 diabetes mellitus . It contains tirzepatide, a first-in-class medication that acts on two incretin hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual agonist mechanism is what sets Mounjaro apart from older diabetes drugs like semaglutide (Ozempic) or liraglutide (Victoza), which only target GLP-1.

Though its initial approval is for diabetes management, Mounjaro is gaining widespread attention for its significant weight loss benefits, with ongoing clinical trials assessing its efficacy in non-diabetic individuals with obesity.

Mechanism of Action: How Mounjaro Works

Mounjaro mimics the effects of two hormones—GIP and GLP-1—which are naturally released in the body after eating. These hormones help regulate insulin secretion, blood sugar levels, and appetite. Here's how it works:

1. Enhances Insulin Secretion

Mounjaro increases insulin production by the pancreas when blood sugar levels are elevated, particularly after meals. This helps the body manage glucose more effectively, reducing the risk of sharp sugar spikes. By responding only when glucose is high, it avoids unnecessary insulin release. This targeted action improves overall blood sugar control.

2. Reduces Glucagon Levels

Glucagon is a hormone that tells the liver to release stored sugar into the bloodstream. In type 2 diabetes, glucagon levels can remain high even when blood sugar doesn’t need to be elevated. Mounjaro lowers glucagon secretion, preventing excess sugar release. This contributes to smoother and more stable blood glucose levels.

3. Slows Gastric Emptying

Mounjaro slows down how quickly food moves from the stomach to the intestines after eating. As a result, people feel fuller for a longer time, which helps control appetite. This slower digestion also reduces the rate at which glucose enters the bloodstream. It supports both weight management and improved blood sugar response.

4. Improves Insulin Sensitivity

Many people with type 2 diabetes have insulin resistance, where the body doesn’t respond properly to insulin. Mounjaro helps improve insulin sensitivity, allowing cells in muscles and fat to absorb glucose more efficiently. This reduces the amount of sugar in the blood. Better insulin action leads to more effective glucose regulation and metabolic health.

Mounjaro for Type 2 Diabetes

For individuals with type 2 diabetes, managing blood sugar can often involve multiple medications, lifestyle changes, and constant monitoring. Mounjaro offers a more comprehensive approach by addressing multiple pathways that affect glucose levels. Clinical trials (like SURPASS-1 through SURPASS-5) have shown that Mounjaro outperforms many existing treatments in reducing HbA1c levels, a key marker for long-term blood sugar control.

Patients on Mounjaro often experience:

• Reduced fasting and post-meal glucose levels

• A1c reductions up to 2.5%

• Improved insulin resistance

Mounjaro and Weight Loss

One of the most talked-about benefits of Mounjaro is its significant impact on weight loss, even among people who do not have diabetes. In clinical trials, participants experienced an average reduction of 15–20% in total body weight over several months of consistent use. This is a substantial achievement compared to older medications and even some bariatric procedures.

Mounjaro works by mimicking the effects of two gut hormones, GLP-1 and GIP, that help regulate blood sugar and suppress appetite. It slows down gastric emptying, which means food stays in the stomach longer, helping users feel full and satisfied with smaller meals. It also influences hunger signals in the brain, leading to reduced cravings and emotional eating.

Interestingly, many users report a natural shift in food preferences, often gravitating toward healthier, less energy-dense foods. This behavioral change, combined with hormonal regulation, makes weight loss more sustainable. Because obesity is deeply linked to insulin resistance and metabolic issues, Mounjaro also helps treat the underlying causes of weight gain. Its dual mechanism offers hope for people struggling with weight despite diet and exercise efforts.

Mounjaro for Weight Loss:

• Helps reduce 15–20% of body weight on average over time.

• Slows digestion to increase feelings of fullness and reduce hunger.

• Suppresses appetite by acting on hunger-regulating brain pathways.

• Encourages healthier food choices and reduces cravings.

• Offers a dual benefit for both weight loss and blood sugar control.

• Currently under study for approval as a dedicated weight-loss drug.

• Particularly useful for patients with obesity-related metabolic issues. A promising non-surgical option for long-term weight management.

For expert guidance on weight loss solutions, Elevate Now offers alternatives like GLP-1 medications with a doctor-led approach that assesses eligibility, identifies root causes, and provides medically guided, personalized strategies.

Choose Elevate Now for Effective Weight Loss?

• Doctor-Led Medical Weight Loss – A science-backed, root cause-focused approach to sustainable weight management.
• In-Depth Diagnosis – 80+ weight-loss-specific blood tests analyzed by NABL-accredited labs for precise metabolic assessment.
• Expert Medical Team – Led by Dr. Neeta Deshpande, one of India’s top obesity specialists, ensuring safe and effective treatment.
• Customized Medications – Tailored GLP-1 protocols, appetite suppressants, and diabetes-specific treatments designed for Indian lifestyles. (Check your eligibility here)
• Holistic Lifestyle Coaching – Certified experts providing personalized nutrition, fitness, sleep, and stress management support.

Mounjaro Dosing and Administration Guide

Who Should Avoid Mounjaro?

Mounjaro may not be suitable for everyone. Contraindications and precautions include:

• History of medullary thyroid carcinoma (MTC)

• Personal or family history of MEN 2 (Multiple Endocrine Neoplasia syndrome)

• Severe gastrointestinal disease

• Pregnant or breastfeeding individuals

• Type 1 diabetes (not approved for use)

Always consult a doctor to determine suitability based on individual health conditions and medications.

Availability in India

Mounjaro was recently launched in the Indian market in 2025, bringing a world-class therapeutic option to Indian patients. It is currently available in select metros and major hospitals, with a gradual rollout expected across the country.

The price point in India is still considered high compared to conventional medications, but many see it as a worthy investment for those battling both obesity and diabetes.

Get expert-backed weight loss solutions with Elevate Now, where doctors assess eligibility, identify underlying factors, and guide you with medically supervised GLP-1 alternatives.

Conclusion

Mounjaro represents a new chapter in chronic disease management by combining dual hormone action, convenient weekly dosing, and powerful effects on both blood sugar and body weight. As it becomes more widely available in India, it offers hope to millions living with type 2 diabetes and obesity. Though not without side effects and precautions, Mounjaro’s innovative mechanism and real-world results make it one of the most promising drugs of this decade.